Compare Fajar Surya Wisesa Tbk. (FASW) vs Millennium Pharmacon International Tbk. (SDPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fajar Surya Wisesa Tbk. vs Millennium Pharmacon International Tbk. — how do they compare? Fajar Surya Wisesa Tbk. trades at Rp5,275 (market cap 16.99T), while Millennium Pharmacon International Tbk. trades at Rp196 (market cap 252.25B, 123.4K 24h volume). The key difference: Fajar Surya Wisesa Tbk. is far larger — about 67.4× Millennium Pharmacon International Tbk.'s market cap. Which is the better fit depends on your goals.
| FASW | SDPC | |
|---|---|---|
Market Cap | 16.99T | 252.25B |
Volume | — | 123.4K |
Lot | — | 1.23K |
Turnover | — | 24.17M |
Average Price | — | 195.88 |
Value | — | 24.17M |
Indicative Equilibrium Price | — | 196 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fajar Surya Wisesa Tbk.
PT Fajar Surya Wisesa Tbk (the Company) was established based on Notarial Deed No. 20 dated June 13, 1987 of Lenny Budiman, S.H., notary in Jakarta.
Read more on FASW →About Millennium Pharmacon International Tbk.
PT Millennium Pharmacon International Tbk (the Company) was established on October 20th, 1952 under the name N.V. Perusahaan Dagang SOEDARPO CORPORATION. On July 29th, 1997, the Extraordinary Shareholders meeting held by the Company has approved the sale of assets and of the whole share participation on the Company in PT Praweda Ciptakarsa Informatika and PT Sumber Daya Praweda Informatika. In order to strengthen its equity and settle the foreign currently loan, the Company has conducted its first Right Issue and has submitted the registration statement on May 8th, 2000 to the Capital Advisory Board (BAPEPAM). The Company started its operations on October 20, 1952. The name was changed from previous name PT NVPD Soedarpo Corporation.
Read more on SDPC →
